HDAC6 Mediates Macrophage iNOS Expression and Excessive Nitric Oxide Production in the Blood During Endotoxemia by Wang, Yan et al.
University of Kentucky 
UKnowledge 
Toxicology and Cancer Biology Faculty 
Publications Toxicology and Cancer Biology 
8-20-2020 
HDAC6 Mediates Macrophage iNOS Expression and Excessive 
Nitric Oxide Production in the Blood During Endotoxemia 
Yan Wang 
University of Kentucky 
Ke Wang 
The Second Hospital of Jilin University, China 
Jian Fu 
University of Kentucky, jian.fu@uky.edu 
Follow this and additional works at: https://uknowledge.uky.edu/toxicology_facpub 
 Part of the Medical Immunology Commons, and the Medical Toxicology Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Repository Citation 
Wang, Yan; Wang, Ke; and Fu, Jian, "HDAC6 Mediates Macrophage iNOS Expression and Excessive Nitric 
Oxide Production in the Blood During Endotoxemia" (2020). Toxicology and Cancer Biology Faculty 
Publications. 93. 
https://uknowledge.uky.edu/toxicology_facpub/93 
This Article is brought to you for free and open access by the Toxicology and Cancer Biology at UKnowledge. It has 
been accepted for inclusion in Toxicology and Cancer Biology Faculty Publications by an authorized administrator 
of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
HDAC6 Mediates Macrophage iNOS Expression and Excessive Nitric Oxide Production 
in the Blood During Endotoxemia 
Notes/Citation Information 
Published in Frontiers in Immunology, v. 11, article 1893. 
© 2020 Wang, Wang and Fu. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) 
and the copyright owner(s) are credited and that the original publication in this journal is cited, in 
accordance with accepted academic practice. No use, distribution or reproduction is permitted which 
does not comply with these terms. 
Digital Object Identifier (DOI) 
https://doi.org/10.3389/fimmu.2020.01893 
This article is available at UKnowledge: https://uknowledge.uky.edu/toxicology_facpub/93 
ORIGINAL RESEARCH
published: 20 August 2020
doi: 10.3389/fimmu.2020.01893
Frontiers in Immunology | www.frontiersin.org 1 August 2020 | Volume 11 | Article 1893
Edited by:
Haichao Wang,
Feinstein Institute for Medical
Research, United States
Reviewed by:
Xin Ni,
Second Military Medical
University, China
Chuanfu Li,
East Tennessee State University,
United States
*Correspondence:
Jian Fu
jian.fu@uky.edu
Specialty section:
This article was submitted to
Inflammation,
a section of the journal
Frontiers in Immunology
Received: 28 April 2020
Accepted: 14 July 2020
Published: 20 August 2020
Citation:
Wang Y, Wang K and Fu J (2020)
HDAC6 Mediates Macrophage iNOS
Expression and Excessive Nitric Oxide
Production in the Blood During
Endotoxemia.
Front. Immunol. 11:1893.
doi: 10.3389/fimmu.2020.01893
HDAC6 Mediates Macrophage iNOS
Expression and Excessive Nitric
Oxide Production in the Blood During
Endotoxemia
Yan Wang 1,2, Ke Wang 1 and Jian Fu 2*
1Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China,
2Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, United States
Excessive nitric oxide (NO) production and NO-mediated nitrative stress contribute to
vascular dysfunction, inflammation, and tissue injury in septic shock. New therapeutic
targets are urgently needed to provide better control of NO level during septic shock.
In the present study, we investigated the role of HDAC6 in the regulation of NO
production and nitrative stress in a mouse model of endotoxin-induced septic shock.
HDAC6 deficient mice and a specific HDAC6 inhibitor were utilized in our studies.
Our data clearly indicate that HDAC6 is an important mediator of NO production
in macrophages. HDAC6 mediates NO production through the regulation of iNOS
expression in macrophages. HDAC6 up-regulates iNOS expression in macrophages by
modulating STAT1 activation and IRF-1 expression. HDAC6 inhibition potently blocked
endotoxin-induced STAT1 activation and iNOS expression inmacrophages. Furthermore,
HDAC6 contributes to excessive NO production and nitrotyrosine level in the blood and
promotes iNOS expression in the lung tissues during septic shock. Our data reveal a
novel HDAC6/STAT1/iNOS pathway that mediates excessive NO production and nitrative
stress in septic shock.
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INTRODUCTION
Sepsis is a life-threatening disease that is defined asmulti-organ dysfunction caused by dysregulated
host responses to infection (1–5). Sepsis remains a major health problem worldwide (1, 4, 5). Septic
shock, which is characterized by hypotension and hyporeactivity to vasoconstrictors, is a main
cause of high mortality in sepsis patients (5–8). Septic shock leads to reduced blood and oxygen
flow to vital organs, which eventually causes multi-organ failure and death (5–8). Endotoxemia is a
major factor in the pathogenesis of septic shock (2, 3). Endotoxemia is caused by elevated levels of
circulating bacterial endotoxin (2, 3), a lipopolysaccharide (LPS) component of the Gram-negative
bacterial outer membrane. Endotoxemia has been detected in the critically ill sepsis patients (2, 3).
Nitric oxide (NO) has been identified as a key endogenous regulator of vascular tone (5–9). It
is now well-established that excessive NO production contributes to vascular dysfunction during
septic shock including vasodilation, vascular hyporeactivity, and vascular hyperpermeability (5–9).
The stable NO metabolites nitrite and nitrate have been used as the indicators of NO production
(5–9). The levels of the NO metabolites are increased during septic shock (5–9).
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NO can also react with superoxide anion (O2− ) to form highly
cytotoxic oxidant peroxynitrite (ONOO−) (8–10). Nitrative
stress is induced by peroxynitrite oxidation of lipids, proteins,
and nucleic acids (8–10). Nitrative stress causes cytotoxicity in
tissues and contributes to multi-organ injury in sepsis such as
endothelial injury and vascular dysfunction (8–10).
NO is generated by nitric oxide synthases (NOS) through
metabolism of L-arginine (9, 11, 12). The constitutively expressed
endothelial NOS (eNOS) and neuronal NOS (nNOS) are thought
to contribute to the physiological levels of NO (9, 11, 12). The
inducible nitric oxide synthase (iNOS) is responsible for a large
production of NO during inflammatory responses and disease
states (9, 11, 12). iNOS can be expressed by a variety of cells and
tissues including macrophages and neutrophils (9, 11, 12). iNOS
expression in leukocytes is induced during sepsis (6, 8, 9, 13),
which leads to high NO production in septic shock (6, 8, 9, 13).
The NO generation through iNOS induction is one of the host
defense mechanisms against bacterial infection (6, 8, 9, 13).
However, excessive iNOS induction can lead to shock and tissue
damage (6, 8, 9, 13).
iNOS expression is mainly regulated at the transcriptional
level (8, 9, 12, 13). Activation of transcription factors such as
nuclear factor κB (NFκB) and Signal transducer and activator
of transcription 1 (STAT1) are needed for the maximal iNOS
expression (8, 9, 12, 13). The active transcriptional factors
bind to the promoter region of iNOS gene to induce iNOS
expression. STAT-1 activation can also induce the expression of
other regulatory factors such as interferon regulatory factor-1
(IRF-1) (9, 12, 13). IRF-1 then binds to the interferon-
regulatory binding site at the iNOS promoter and facilitates iNOS
expression (9, 12, 13).
HDAC6 (histone deacetylase 6) is a member of class II histone
deacetylase that modulates the dynamics of protein acetylation
and deacetylation (14–16). HDAC6 is mostly localized in the
cytoplasm (14, 15). HDAC6 regulates many cellular responses
and cell signaling pathways including stress responses, cell
proliferation, inflammatory responses, apoptotic signaling, and
transcription (14–16). However, the role of HDAC6 in iNOS
expression and NO production has not been studied. In the
present study, we investigated the role of HDAC6 in iNOS
expression and nitric oxide production in macrophages.
We also investigated the role of HDAC6 in excessive
NO production and nitrative stress in endotoxin-induced
septic shock.
MATERIALS AND METHODS
Reagents
β-actin (Cat#5125), GAPDH (Cat#8884), IRF-1 (Cat#8478),
iNOS (Cat#13120), p-STAT1(Y701) (Cat#7649), STAT1
(Cat#9172) and acetyl-α-tubulin (Lys40) (Cat#5335), HDAC6
(Cat#7612) antibodies were purchased from Cell Signaling
Technology (Danvers, Massachusetts). Lipopolysaccharide (LPS)
from Escherichia coli 0111:B4 (Cat# L4391) was purchased from
Sigma Aldrich (St. Louis, Missouri). CAY10603 (Cat# S7596) was
obtained from Selleck Chemicals (Houston, Texas).
Mouse Model of Endotoxemia
All experiments and animal care procedures conform to the
Guide for the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use Committee
of the University of Kentucky. Wild type C57BL/6J mice
(Stock No: 000664) and HDAC6 knockout C57BL/6J mice (Stock
No:029318) were purchased from The Jackson Laboratory (Bar
Harbor, Maine). The CRISPR/Cas9-generated HDAC6 knockout
C57BL/6J mice carry a HDAC6 gene knock-out mutation.
9- to 12-week-old sex and age-matched wild type C57BL/6J mice
and HDAC6 knockout C57BL/6J mice were used in the studies.
Endotoxemia was induced by IP injection of LPS (7.5 mg/kg body
weight). Experiments were terminated 6 h after LPS challenge.
Blood and lung tissues were collected for the assays.
Isolation of Mouse Peritoneal
Macrophages
Mouse peritoneal macrophages were isolated as described
previously (17). Briefly, after euthanasia, the abdomen skin of
each mouse was socked with 70% alcohol. A small incision was
made to expose the intact peritoneal wall. Five milliliters of
ice-cold RPMI 1640 medium was injected into the peritoneal
cavity. After gentle massage, peritoneal fluid was harvested and
centrifuged at 500 g for 10min at 4◦C. The cells were then
resuspended and cultured in RPMI 1640 containing 10% Fetal
Bovine Serum. Peritoneal cells were allowed to adhere to the
cell culture plates for 4 h at 37◦C in 5% CO2 and 95% air.
The plates were then washed to remove non-adherent cells. The
attachedmacrophages were used for the experiments. Differential
cell staining was performed with a Wright-Giemsa stain set
(astraldiagnostics; Item# 5585). Differential cell counts showed
>97% macrophages. The cell viability was >98% as determined
by trypan blue dye exclusion.
In vitro and in vivo Assays for Nitric Oxide
Production
Nitric oxide production in peritonealmacrophages was examined
by nitrite quantitation using Griess Reagent Kit (Cat# G7921;
Thermo Fisher Scientific; Grand Island, New York) according
to the manufacturer’s protocol. Briefly, peritoneal macrophages
were divided equally and plated in the 96-well plate. After
LPS and CAY10603 treatment, the cell culture supernatant was
collected and mixed with Griess Reagent. The mixture was
incubated for 30min at room temperature. The absorbance was
measured at 548 nm using a plate reader. Nitrite concentration
was then calculated according to the standard curve.
In Vivo blood nitric oxide levels were examined by
nitrite/nitrate quantitation using the Nitric Oxide Colorimetric
Assay Kit (Cat#K262; Biovision; Milpitas, California) according
to the manufacturer’s protocol. Briefly, mouse plasma was
collected and filtered through a 10 KDa cutoff filter, then the
Nitrate Reductase mixture and the enzyme cofactor were added
to the plasma in the plates. The plates were incubated at room
temperature to convert nitrate to nitrite. The enhancer andGriess
Reagent were then added. After the color was developed for
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FIGURE 1 | HDAC6 deletion induces robust α-tubulin acetylation and blocks LPS-induced iNOS expression in peritoneal macrophages. Peritoneal macrophages
isolated from the HDAC6 Knockout and wild type mice were challenged without or with 100 ng/ml LPS for 12 h. Experiments were repeated three times.
Representative blots and densitometry analysis of α-tubulin acetylation (ace-α-tubulin) (A) and iNOS expression (B). *P < 0.05.
10min at room temperature, the absorbance was measured at
540 nm in a plate reader.
In vivo Assay of Nitrotyrosine Levels
Blood nitrotyrosine levels were examined by the Cell
Biolabs OxiSelect Nitrotyrosine Elisa Kit (Cat# STA-305;
San Diego, California) according to the manufacturer’s protocol.
Briefly, mouse plasma was collected and incubated with
anti-nitrotyrosine antibody and the diluted Secondary Antibody-
Enzyme Conjugate. After adding the Substrate Solution and the
enzyme reaction stop solution, the absorbance was measured
immediately at 450 nm in a plate reader.
Immunoblotting Assays
Immunoblotting assays of peritoneal macrophages and lung
tissue samples were performed as described previously (18, 19).
The lung tissues were collected and homogenized in RIPA lysis
buffer. Protein concentrations were measured by a Bicinchoninic
Acid Protein Assay Kit (Cat#A53225; Thermo Fisher Scientific).
The protein samples were separated by electrophoresis on SDS-
PAGE and transferred to polyvinylidenedifluoride membranes.
The membranes were then probed with primary and secondary
antibodies. Blots were developed using a Clarity Western ECL
Substrate (Cat#1705061; Bio-Rad, Hercules, California).
Statistical Analysis
Data are presented as mean ± SEM. ANOVA and post hoc
multiple comparison tests were utilized for multiple groups. The
Student’s t-test was applied for comparisons of two groups. Data
are considered statistically significant with a P-value < 0.05.
RESULTS
To investigate the role of HDAC6 in nitric oxide production, we
first examined the effects of HDAC6 deletion on LPS-induced
iNOS expression in macrophages. Peritoneal macrophages
isolated from the HDAC6 knockout and wild type mice
were challenged with LPS. Our data showed that HDAC6
deletion markedly blocked LPS-induced iNOS expression in the
peritoneal macrophages, which was associated with a robust
increase of α-tubulin acetylation in the peritoneal macrophages
of HDAC6 knockout mice (Figure 1).
To further establish HDAC6 as a target to control iNOS
expression, we also conducted experiments to examine the
effects of HDAC6 inhibition on LPS-induced iNOS expression
in macrophages. CAY10603 is a highly selective and potent
HDAC6 inhibitor with IC50 at 2 pM in a cell-free assay and
>200-fold selectivity over other HDACs (19, 20). Peritoneal
macrophages isolated from the wild type mice were pre-treated
with CAY10603, then challenged with LPS. Consistent with the
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FIGURE 2 | HDAC6 inhibition induces robust α-tubulin acetylation and blocks LPS-induced iNOS expression in peritoneal macrophages. Peritoneal macrophages
isolated from the wild type mice were treated with 0.3µM CAY10603 or control vehicle for 3 h. The macrophages were then challenged without or with 100 ng/ml LPS
for 12 h. Experiments were repeated three times. Representative blots and densitometry analysis of α-tubulin acetylation (ace-α-tubulin) (A) and
iNOS expression (B). *P < 0.05.
effects of HDAC6 deletion, HDAC6 inhibition by CAY10603 also
induced a robust increase of α-tubulin acetylation and blocked
LPS-induced iNOS expression in the peritoneal macrophages
isolated from the wild type mice (Figure 2).
HDAC6 modulates several signaling pathways through
protein deacetylation (14–16). STAT1 activation is needed for
maximal transcriptional up-regulation of iNOS expression (13).
STAT1 phosphorylation at Tyr701 mediates STAT1 dimerization,
nuclear translocation, and DNA binding (21). To investigate
the underlying molecular mechanisms of HDAC6 regulation of
iNOS expression, we examined the effects of HDAC6 deletion
on LPS-induced STAT1 activation in macrophages by examining
STAT1 phosphorylation at Tyr701. Our results showed that
HDAC6 deletion blocked LPS-induced STAT1 activation as
evidenced by the reduction of STAT1 phosphorylation at Tyr701
(Figure 3A). Furthermore, HDAC6 inhibition by CAY10603
showed potent inhibitory effects on LPS-induced STAT1
activation in the peritoneal macrophages isolated from the wild
type mice (Figure 3B).
STAT-1 activation induces the expression IRF-1 (11–13). IRF-
1 promotes iNOS expression by binding to the interferon-
regulatory binding site at the iNOS promoter (11–13). To
further investigate the mechanisms of HDAC6 regulation of
STAT1 activation on iNOS expression, we also examined the
effects of HDAC6 deletion on LPS-induced IRF-1 expression
in macrophages. Consistent with the inhibitory effects on
STAT1 activation, HDAC6 deletion blocked LPS-induced IRF-1
expression in the peritoneal macrophages (Figure 4A). HDAC6
inhibition also showed potent inhibitory effects on LPS-induced
IRF-1 expression in the peritoneal macrophages isolated from the
wild type mice (Figure 4B).
To directly assess the role of HDAC6 on nitric oxide
production, we conducted experiments to examine the effects
of HDAC6 deletion and inhibition on LPS-induced nitric
oxide production in macrophages. The peritoneal macrophages
isolated from the wild type and HDAC6 knockout mice were
challenged with LPS, nitric oxide production was examined by
nitrite quantitation of cell culture supernatant. Our data indicate
that HDAC6 deletion markedly reduced LPS-induced nitric
oxide production in the peritoneal macrophages (Figure 5A).
LPS-induced nitric oxide production was also decreased in the
peritoneal macrophages isolated from the wild typemice after the
pre-treatment with theHDAC6 inhibitor CAY10603 (Figure 5B).
We then investigated HDAC6 regulation of iNOS expression
during septic shock. Septic shock was induced by endotoxin.
iNOS expression in the lung tissues was examined by
immunoblotting assays in the wild type and HDAC6 knockout
mice. Our results showed that HDAC6 deletion led to a robust
increase of α-tubulin acetylation in the lung tissues, which was
associated with a potent blockade of iNOS expression in the
lung tissues (Figure 6). Our data establish an important role of
HDAC6 in the regulation of iNOS expression during septic shock.
We also assessed the role of HDAC6 in excessive nitric
oxide production and NO-mediated nitrative stress during septic
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FIGURE 3 | HDAC6 deletion and inhibition block LPS-induced STAT1 activation in peritoneal macrophages. (A) Peritoneal macrophages isolated from the HDAC6
Knockout and wild type mice were challenged without or with 100 ng/ml LPS for 12 h. (B) Peritoneal macrophages isolated from the wild type mice were treated with
0.3µM CAY10603 or control vehicle for 3 h. The macrophages were then challenged without or with 100 ng/ml LPS for 12 h. Experiments were repeated three times.
Representative blots and densitometry analysis of STAT1 phosphorylation at Tyr701. *P < 0.05.
shock induced by endotoxin. Nitric oxide levels in the blood
of the wild type and HDAC6 knockout mice were examined
by nitrite/nitrate quantitation. Our data showed that HDAC6
deletion significantly reduced nitric oxide levels in the blood
during septic shock (Figure 7A). Furthermore, nitrotyrosine
levels in the blood, an indicator of NO-mediated nitrative stress,
were measured by ELISA. Our results showed that HDAC6
deletion led to a decreased blood nitrotyrosine level during septic
shock (Figure 7B).
DISCUSSION
Dysregulated HDAC6 activity and expression have been reported
to play an important role in the development of human diseases
(14–16, 19). HDAC6 inhibition is a new therapeutic strategy
against inflammation, cancer, and neurological disorders (14–
16, 19). In our studies, HDAC6 deletion reduced the production
of NO in endotoxemia, which is associated with decreased
nitrative stress as evidenced by the reduced nitrotyrosine level
in the blood. Our data suggest that HDAC6 can modulate
NO production and NO-mediated nitrative stress during
septic shock.
Excessive NO production is a major factor in vascular
dysfunction and tissue damage during septic shock (6–9). Nitrite
and nitrate levels in the blood are elevated in sepsis and septic
shock patients (6–9). Lowering NO production has been reported
to help restore blood pressure and improve vascular responses
to vasoconstrictors (6–9). The decreased NO production by
HDAC6 deletion and inhibition could be beneficial to control
vascular responses in septic shock. Furthermore, the level of
NO-generated cytotoxic peroxynitrite is markedly increased
during septic shock (6–10). The nitrosylation of proteins by
peroxynitrite can also alter signal transduction (6–10). Our data
suggest that HDAC6 contributes to the increased peroxynitrite
levels in endotoxemia, which could induce nitrative stress-
mediated cellular responses and tissue injury in septic shock.
HDAC6 and iNOS have been reported to modulate
inflammatory and immune responses in leukocytes (8, 14, 22–
24). However, the interactions of the HDAC6 and iNOS have not
been studied. Our results suggest that HDAC6 is critical for iNOS
expression in leukocytes. Given the important contribution of
NO in leukocyte immune responses and cytotoxic activity
(8, 14, 22, 23), HDAC6 regulation of iNOS expression could
affect many cellular responses of leukocytes. More studies are
needed in the future to further explore these responses.
Up-regulation of iNOS expression and the resultant high NO
production have been known to contribute to the development of
cardiovascular diseases (6–10, 12). In pathophysiological settings,
induction of iNOS is associated with detrimental effects such as
life-threatening hypotension and cytotoxicity (6–10, 12). iNOS
expression is induced during endotoxemia at both mRNA and
protein levels (6–10, 12). Leukocytes such as macrophages are
major cell types with iNOS induction and contribute significantly
to the NO over-production in sepsis (6–9). iNOS-deficient mice
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FIGURE 4 | HDAC6 deletion and inhibition block LPS-induced IRF-1 expression in peritoneal macrophages. (A) Peritoneal macrophages isolated from the HDAC6
knockout and wild type mice were challenged without or with 100 ng/ml LPS for 12 h. (B) Peritoneal macrophages isolated from the wild type mice were treated with
CAY10603 0.3µM or control vehicle for 3 h. The macrophages were then challenged without or with LPS 100 ng/ml for 12 h. Experiments were repeated three times.
Representative blots and densitometry analysis of IRF-1 expression. *P < 0.05.
FIGURE 5 | HDAC6 deletion and inhibition suppress LPS-induced nitric oxide production in peritoneal macrophages. (A) Peritoneal macrophages (150,000 cells/well)
isolated from the HDAC6 knockout and wild type mice were challenged without or with 100 ng/ml LPS for 12 h. (B) Peritoneal macrophages (325,000 cells/well)
isolated from the wild type mice were treated with 0.3µM CAY10603 or control vehicle for 3 h. The macrophages were then challenged without or with 100 ng/ml LPS
for 12 h. Nitric oxide production in peritoneal macrophages was assessed by nitrite quantitation. *P < 0.05.
exhibited alleviated hypotension and reduced early mortality
during endotoxemia (25), suggesting that iNOS over-expression
could lead to vascular dysfunction and tissue injury in septic
shock. Our data provide direct evidence that HDAC6 is a key
regulator of endotoxin-induced iNOS expression inmacrophages
and iNOS expression in tissues during endotoxemia. Our
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FIGURE 6 | HDAC6 deletion induces robust α-tubulin acetylation and blocks iNOS expression in the lung tissues during endotoxemia. The HDAC6 knockout mice
and wild type mice were divided into four groups: Wild Type (Wild type mice treated with PBS, n = 6); HDAC6 knockout (HDAC6 knockout mice treated with PBS,
n = 6); Wild Type/LPS (Wild type mice challenged with LPS, n = 9), and HDAC6 knockout/LPS (HDAC6 knockout mice challenged with LPS, n = 9). The mice were
challenged with LPS. 6 h after LPS challenge, lung tissues were collected. Representative blots and densitometry analysis of α-tubulin acetylation (ace-α-tubulin) (A)
and iNOS expression (B). *P < 0.05.
FIGURE 7 | HDAC6 deletion alleviates nitric oxide over-production and nitrative stress in the blood during endotoxemia. The HDAC6 knockout mice and wild type
mice were divided into four groups: Wild Type (Wild type mice treated with PBS, n = 6); HDAC6 knockout (HDAC6 knockout mice treated with PBS, n = 6); Wild
Type/LPS (Wild type mice challenged with LPS, n = 8), and HDAC6 knockout/LPS (HDAC6 knockout challenged with LPS, n = 8). The mice were challenged by LPS.
6 h after LPS challenge. (A) Blood nitric oxide levels were examined by nitrite/nitrate quantitation. (B) Blood nitrotyrosine levels were examined by ELISA. *P < 0.05.
Frontiers in Immunology | www.frontiersin.org 7 August 2020 | Volume 11 | Article 1893
Wang et al. HDAC6 Regulates Nitric Oxide Production
findings provide a new approach to intervene iNOS expression
in leukocytes, which could improve the outcomes of septic shock
such as hypotension and vascular hyporeactivity.
HDAC6 is cytoplasmic deacetylase that can deacetylate
a variety of endogenous substrates such as tubulin (14–
16, 19, 26). The regulation of tubulin acetylation/deacetylation
states by HDAC6 could modulate microtubule-mediated
biological responses, cellular function and signaling (14–16, 19).
Microtubule and tubulin can bind to JAK (Janus tyrosine kinases)
and STAT1 to facilitate the activation and nuclear translocation
of STAT1 (27). HDAC6 has been reported to regulate α-tubulin
acetylation/deacetylation and microtubule stabilization (28),
indicating that HDAC6 is a potential modulator of microtubule-
mediated STAT1 signaling. Our results showed that HDAC6 is
need for LPS-induced STAT1 activation. Both HDAC6 deletion
and inhibition led to potent inhibition of STAT1 activation
and α-tubulin acetylation. Our data reveal a new HDAC6-
regulated STAT1 signaling pathway, likely through α-tubulin
and microtubule modification.
The role of HDAC6 in macrophage function and NO
production remains large unknown. Our data suggest that
HDAC6 is a key mediator of STAT1 activation, iNOS expression,
and nitric oxide production in macrophages. Our findings unveil
a new HDAC6-regulated cell signaling and iNOS expression
pathway in macrophages. Furthermore, our results indicate that
HDAC6 mediates iNOS expression in endotoxin-induced septic
shock. HDAC6 could be a potential therapeutic target to control
iNOS expression in septic shock.
In Summary, our results suggest that HDAC6 is a keymediator
of NO over-production in endotoxemia. HDAC6 regulates LPS-
induced iNOS expression in macrophages by modulating STAT1
activation and IRF-1 expression, and facilitates iNOS expression
in the tissues during endotoxemia. HDAC6 inhibition could be a
new therapeutic approach to control NO level and nitrative stress
during septic shock, which could improve vascular responses and
alleviate tissue injury in septic shock.
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